FDA Inspection 1316700 — Tarek Alhamad, MD
The FDA completed an inspection of Tarek Alhamad, MD on May 1, 2026 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 1, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Saint Louis, MO (United States)
Additional Details
Clinical Investigator (CI)